236 related articles for article (PubMed ID: 36825723)
1. Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents.
Yang J; Lv J; Cheng S; Jing T; Meng T; Huo D; Ma X; Wen R
Anticancer Agents Med Chem; 2023; 23(11):1265-1283. PubMed ID: 36825723
[TBL] [Abstract][Full Text] [Related]
2. Chalcone Derivatives: Role in Anticancer Therapy.
Ouyang Y; Li J; Chen X; Fu X; Sun S; Wu Q
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208562
[TBL] [Abstract][Full Text] [Related]
3. Chalcone Scaffolds as Anticancer Drugs: A Review on Molecular Insight in Action of Mechanisms and Anticancer Properties.
Shukla S; Sood AK; Goyal K; Singh A; Sharma V; Guliya N; Gulati S; Kumar S
Anticancer Agents Med Chem; 2021; 21(13):1650-1670. PubMed ID: 33238850
[TBL] [Abstract][Full Text] [Related]
4. Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure-activity relationship.
Gao F; Huang G; Xiao J
Med Res Rev; 2020 Sep; 40(5):2049-2084. PubMed ID: 32525247
[TBL] [Abstract][Full Text] [Related]
5. Anticancer Activity of Natural and Synthetic Chalcones.
Constantinescu T; Lungu CN
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768736
[TBL] [Abstract][Full Text] [Related]
6. Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer.
WalyEldeen AA; Sabet S; El-Shorbagy HM; Abdelhamid IA; Ibrahim SA
Chem Biol Interact; 2023 Jan; 369():110297. PubMed ID: 36496109
[TBL] [Abstract][Full Text] [Related]
7. Recent Advancement in Bioactive Chalcone Hybrids as Potential Antimicrobial Agents in Medicinal Chemistry.
Maurya A; Agrawal A
Mini Rev Med Chem; 2024; 24(2):176-195. PubMed ID: 37497710
[TBL] [Abstract][Full Text] [Related]
8. Natural Chalcones and Their Derivatives Target the Tumor Microenvironment in Colon Cancer.
Malla RR; Siragam S; Dadi V; Seetini B
Crit Rev Immunol; 2022; 42(6):27-39. PubMed ID: 37082949
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapeutics Applications and Chemistry of Chalcone Derivatives.
Dhaliwal JS; Moshawih S; Goh KW; Loy MJ; Hossain MS; Hermansyah A; Kotra V; Kifli N; Goh HP; Dhaliwal SKS; Yassin H; Ming LC
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296655
[TBL] [Abstract][Full Text] [Related]
10. Chalcones against the hallmarks of cancer: a mini-review.
de Souza PS; Bibá GCC; Melo EDDN; Muzitano MF
Nat Prod Res; 2022 Sep; 36(18):4809-4826. PubMed ID: 34865580
[TBL] [Abstract][Full Text] [Related]
11. Chalcones: Synthetic Chemistry Follows Where Nature Leads.
Jasim HA; Nahar L; Jasim MA; Moore SA; Ritchie KJ; Sarker SD
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439870
[TBL] [Abstract][Full Text] [Related]
12. Efficient access to domain-integrated estradiol-flavone hybrids via the corresponding chalcones and their in vitro anticancer potential.
Molnár B; Gopisetty MK; Nagy FI; Adamecz DI; Kása Z; Kiricsi M; Frank É
Steroids; 2022 Nov; 187():109099. PubMed ID: 35970223
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Chalcone-Based Anticancer Heterocycles: A Structural and Molecular Target Perspective.
Kumar V; Dhawan S; Girase PS; Awolade P; Shinde SR; Karpoormath R; Singh P
Curr Med Chem; 2021 Oct; 28(33):6805-6845. PubMed ID: 33749549
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities.
Srinivasan B; Johnson TE; Lad R; Xing C
J Med Chem; 2009 Nov; 52(22):7228-35. PubMed ID: 19883086
[TBL] [Abstract][Full Text] [Related]
15. Heterocyclic chalcone analogues as potential anticancer agents.
Sharma V; Kumar V; Kumar P
Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
[TBL] [Abstract][Full Text] [Related]
16. Chalcone Scaffolds, Bioprecursors of Flavonoids: Chemistry, Bioactivities, and Pharmacokinetics.
Rudrapal M; Khan J; Dukhyil AAB; Alarousy RMII; Attah EI; Sharma T; Khairnar SJ; Bendale AR
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885754
[TBL] [Abstract][Full Text] [Related]
17. Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications.
Mahapatra DK; Bharti SK; Asati V; Singh SK
Eur J Med Chem; 2019 Jul; 174():142-158. PubMed ID: 31035237
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Caco-2 and MCF-7 cancer cells using chalcones: synthesis, biological evaluation and computational study.
Mellado M; Reyna-Jeldes M; Weinstein-Oppenheimer C; Coddou C; Jara-Gutierrez C; Villena J; Aguilar LF
Nat Prod Res; 2022 Sep; 36(17):4410-4416. PubMed ID: 34583595
[TBL] [Abstract][Full Text] [Related]
19. The Quinazoline-Chalcone and Quinazolinone-Chalcone Hybrids: A Promising Combination for Biological Activity.
Mass EB; Duarte GV; Russowsky D
Mini Rev Med Chem; 2021; 21(2):186-203. PubMed ID: 32744973
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin.
He M; Yu M; Li C; Meng X; Su J; Zhu Y; Yao R
Anticancer Agents Med Chem; 2022; 22(10):1945-1961. PubMed ID: 34674626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
